At the transcriptional level, treatment with the nitrocompounds resulted in the downregulation of G6PD, SIRT2, and VEGF gene expression, which may contribute to reduced glioblastoma cell proliferation and impaired adaptation to hypoxic stress. The gene discussed is VEGFA; the disease is glioblastoma.